Abstract
Since late 2019 and early 2020, with the emergence of the COVID-19 pandemic, scientists are rushing to develop treatment and prevention methods to combat SARS-CoV-2. Among these are vaccines. In view of this, the use of animals as experimental models, both to investigate the immunopathology of the disease and to evaluate the efficacy and safety of vaccines, is mandatory. This work aims to describe, through recent scientific articles found in reliable databases, the animal models used for the in vivo testing of COVID-19 vaccines, demonstrating some possibilities of more advantageous/gold-standard models for SARS-CoV-2 vaccines. The majority of the studies use rodents and primates. Meanwhile, the most adequate model to be used as the gold standard for in vivo tests of COVID-19 vaccines is not yet conclusive. Promising options are being discussed as new tests are being carried out and new SARS-CoV-2 variants are emerging.
Funder
Fundação de Amparo à Pesquisa do Estado de São Paulo
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Subject
Infectious Diseases,Microbiology (medical),General Immunology and Microbiology,Molecular Biology,Immunology and Allergy
Reference110 articles.
1. Characteristics of SARS-CoV-2 and COVID-19;Hu;Nat. Rev. Microbiol.,2021
2. SARS-CoV-2: Taxonomy, origin and constitution;Khalil;Rev. Med.,2020
3. Imunopatologia da COVID-19 e suas implicações clínicas;Aarestrup;Arq. Asmas. Alerg. E Imunol.,2020
4. Coronavirus Spike Protein and Tropism Changes;Hulswit;Adv. Virus Res.,2016
5. A review on evolution of emerging SARS-CoV-2 variants based on spike glycoprotein;Ghosh;Int. Immunopharmacol.,2022
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献